International Multicenter Analysis of Brain Structure Across Clinical Stages of Parkinson's Disease

Brain structure abnormalities throughout the course of Parkinson's disease have yet to be fully elucidated.

[1]  Houeto Jean-Luc.  [Parkinson's disease]. , 2022, La Revue du praticien.

[2]  Guanyu Zhu,et al.  The morphology of thalamic subnuclei in Parkinson's disease and the effects of machine learning on disease diagnosis and clinical evaluation , 2020, Journal of the Neurological Sciences.

[3]  Rebecca C. Knickmeyer,et al.  ENIGMA and global neuroscience: A decade of large-scale studies of the brain in health and disease across more than 40 countries , 2019, Biological Psychiatry.

[4]  Dan J. Stein,et al.  An Empirical Comparison of Meta- and Mega-Analysis With Data From the ENIGMA Obsessive-Compulsive Disorder Working Group , 2019, Front. Neuroinform..

[5]  A. Griffa,et al.  Network connectivity determines cortical thinning in early Parkinson’s disease progression , 2017, bioRxiv.

[6]  A. Dagher,et al.  Clinical criteria for subtyping Parkinson’s disease: biomarkers and longitudinal progression , 2017, Brain : a journal of neurology.

[7]  Marios Politis,et al.  Cognitive decline in Parkinson disease , 2017, Nature Reviews Neurology.

[8]  Ole Isacson,et al.  The Threshold Theory for Parkinson's Disease , 2017, Trends in Neurosciences.

[9]  M. Hallett,et al.  Parkinson’s disease as a system-level disorder , 2016, npj Parkinson's Disease.

[10]  Benjamin S Aribisala,et al.  Novel genetic loci underlying human intracranial volume identified through genome-wide association , 2016, Nature Neuroscience.

[11]  A. Lees,et al.  Visual dysfunction in Parkinson’s disease , 2016, Brain : a journal of neurology.

[12]  Mark Jenkinson,et al.  Automatic segmentation of the striatum and globus pallidus using MIST: Multimodal Image Segmentation Tool , 2016, NeuroImage.

[13]  Martin J. McKeown,et al.  Morphological alterations in the caudate, putamen, pallidum, and thalamus in Parkinson's disease , 2015, Front. Neurosci..

[14]  P. Svenningsson,et al.  Initial cognitive decline is associated with cortical thinning in early Parkinson disease , 2014, Neurology.

[15]  Roger A. Barker,et al.  Cognitive Impairment in Parkinson's Disease: The Dual Syndrome Hypothesis , 2012, Neurodegenerative Diseases.

[16]  P. Svenningsson,et al.  Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment , 2012, The Lancet Neurology.

[17]  A. Singleton,et al.  The Parkinson Progression Marker Initiative (PPMI) , 2011, Progress in Neurobiology.

[18]  R. Albin,et al.  The cholinergic system and Parkinson disease , 2011, Behavioural Brain Research.

[19]  Gary King,et al.  MatchIt: Nonparametric Preprocessing for Parametric Causal Inference , 2011 .

[20]  W. Oyen,et al.  Pallidal dysfunction drives a cerebellothalamic circuit into Parkinson tremor , 2011, Annals of neurology.

[21]  Sébastien Ourselin,et al.  Head size, age and gender adjustment in MRI studies: a necessary nuisance? , 2010, NeuroImage.

[22]  Nan Luo,et al.  Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times , 2010, Movement disorders : official journal of the Movement Disorder Society.

[23]  G. Halliday,et al.  The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years , 2008, Movement disorders : official journal of the Movement Disorder Society.

[24]  I. Cuthill,et al.  Effect size, confidence interval and statistical significance: a practical guide for biologists , 2007, Biological reviews of the Cambridge Philosophical Society.

[25]  Anders M. Dale,et al.  An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest , 2006, NeuroImage.

[26]  J. Cummings,et al.  The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.

[27]  Abraham Z. Snyder,et al.  A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual measurement of total intracranial volume , 2004, NeuroImage.

[28]  W. Poewe,et al.  Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease , 2004, Movement disorders : official journal of the Movement Disorder Society.

[29]  Hansjürgen Bratzke,et al.  Stages in the development of Parkinson’s disease-related pathology , 2004, Cell and Tissue Research.

[30]  D. Brooks.  Neuroimaging in Parkinson’s disease , 2004, NeuroRX.

[31]  A. Dale,et al.  Whole Brain Segmentation Automated Labeling of Neuroanatomical Structures in the Human Brain , 2002, Neuron.

[32]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[33]  Julie M. Hall,et al.  Neural Correlates of Cognitive Impairment in Parkinson's Disease: A Review of Structural MRI Findings. , 2019, International review of neurobiology.

[34]  A. Tessitore,et al.  Structural MRI in Idiopathic Parkinson's Disease. , 2018, International review of neurobiology.

[35]  J. Volkmann,et al.  Parkinson disease , 2017, Nature Reviews Disease Primers.